ArticleJournal of pharmaceutical health care and sciences2025
A survey on the awareness of a sleep-medication formulary in community health care and its influence on prescribing behavior.
Article in Journal of pharmaceutical health care and sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDespite the increasing emphasis on safe prescribing, the impact of local formularies on physician behavior remains underexplored in community healthcare settings. To promote safer pharmacological practices, our institution implemented a hospital-originated sleep-medication formulary in January 2022, which was subsequently disseminated to other local medical institutions in early 2023. This study assessed physicians' awareness of this sleep-medication formulary, and its influence on prescribing behavior in local community healthcare settings.
methodsA questionnaire survey was distributed via a regional medical-cooperation newsletter and responses were received from 84 physicians.
resultsOf the 84 physicians, 18% were aware of the formulary. Physicians in the awareness group were more likely to prescribe the recommended medications, particularly orexin receptor antagonists, and reported significantly less difficulty in initiating hypnotic therapy. Logistic regression analysis revealed a significant association between formulary awareness and reduced difficulty in prescribing a suitable hypnotic (odds ratio: 0.24; 95% CI: 0.073-0.78).
conclusionsLocal formularies may serve as valuable tools in clinical decision-making and promote safer and more consistent prescribing practices. Strategies such as physician education, concise formulary reference sheets or physician-oriented pocket references, and the development of patient-friendly information materials are warranted to support broader implementation.
trial registrationNot applicable.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.